Literature DB >> 22627262

Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai-Dorfman disease.

Wenjun Wu1, Ling Cao, Yanyuan Li, Xinru Yu, He Huang, Jingsong He.   

Abstract

Rosai-Dorfman disease (RDD) is a rare macrophage-related histiocytic disorder that occurs primarily in lymph nodes or extranodal sites. Primary splenic lymphoma is an even rarer form of malignant lymphoma exhibiting characteristic diagnosis, treatment and outcome that have been poorly documented. Documentation of a rare case of primary splenic diffuse large B-cell lymphoma concomitant with isolated thymus RDD is reported in a 42-year-old male patient who was admitted to our hospital for persistent fever and splenomegaly after diagnostic thymectomy. On pathological review of the patient's resected thymus tissue, notable characteristics of thymus RDD were observed. The patient's condition quickly deteriorated, and the spleen progressively enlarged over the course of steroid treatment in our facility. Subsequent diagnostic splenectomy results indicated that non-Hodgkin's lymphoma (nongerminal center diffuse large B-cell lymphoma) was present in splenic tissues. Results of the current case study suggest that early exclusion of possible lymphoma is necessary in RDD patients who exhibit limited or no response to steroid therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22627262     DOI: 10.1097/MAJ.0b013e31824e940d

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Distribution of malignant lymphomas in the anterior mediastinum: a single-institution study of 76 cases in Japan, 1997-2016.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Tomotaka Suzuki; Sayako Yuda; Kosuke Toyoda; Nobuhiko Yamauchi; Shinichi Makita; Suguru Fukuhara; Wataru Munakata; Dai Maruyama; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2017-09-18       Impact factor: 2.490

2.  An extremely rare case of Rosai-Dorfman disease in the thymus.

Authors:  Cheng Shen; Hu Liao
Journal:  J Cardiothorac Surg       Date:  2021-07-31       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.